Global Oligonucleotide Synthesis Market 2022-2028

Global Oligonucleotide Synthesis Market 2022-2028

Oligonucleotide synthesis is the chemical process by which nucleotides are specifically linked to form the desired sequenced product. The technique is extremely useful in current laboratory practice because it provides a rapid and inexpensive access to custom-made oligonucleotides of the desired sequence. Garnering a CAGR of 9.7% from 2022 to 2028, the global oligonucleotide synthesis market is projected to reach worth of USD 10,989 million by 2028-end, according to a new report by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global oligonucleotide synthesis market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the oligonucleotide synthesis industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, application, end user, and region. The global market for oligonucleotide synthesis can be segmented by product: oligonucleotide drugs, synthesized oligonucleotides, reagents, equipment, services. The oligonucleotide drugs segment held the largest share of the global oligonucleotide synthesis market in 2021 and is anticipated to hold its share during the forecast period. Oligonucleotide synthesis market is further segmented by application: diagnostics, therapeutics, research. Globally, the research segment made up the largest share of the oligonucleotide synthesis market. Based on end user, the oligonucleotide synthesis market is segmented into: pharmaceutical & biotechnology companies, diagnostic laboratories, academic research institutes. The academic research institutes segment was the largest contributor to the global oligonucleotide synthesis market in 2021. On the basis of region, the oligonucleotide synthesis market also can be divided into: North America, Asia Pacific, Europe, Rest of the World (ROW). North America is estimated to account for the largest share of the global oligonucleotide synthesis market.

By product:

• oligonucleotide drugs
• synthesized oligonucleotides
• reagents
• equipment
• services

By application:

• diagnostics
• therapeutics
• research

By end user:

• pharmaceutical & biotechnology companies
• diagnostic laboratories
• academic research institutes

By region:

• North America
• Asia Pacific
• Europe
• Rest of the World (ROW)

The global oligonucleotide synthesis market report offers detailed information on several market vendors, including Agilent Technologies, Inc., Biolegio BV, Biolytic Lab Performance, Inc., CustomArray, Inc., Danaher Corporation, Eurofins Scientific SE, LGC Ltd., Merck KGaA, Microsynth AG, Thermo Fisher Scientific Inc., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global oligonucleotide synthesis market.
• To classify and forecast the global oligonucleotide synthesis market based on product, application, end user, region.
• To identify drivers and challenges for the global oligonucleotide synthesis market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global oligonucleotide synthesis market.
• To identify and analyze the profile of leading players operating in the global oligonucleotide synthesis market.

Why Choose This Report

• Gain a reliable outlook of the global oligonucleotide synthesis market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.